BPC-157 has shown a modulatory not suppressive effect on inflammation in research models, reducing cytokine-driven tissue damage while preserving normal immune function.10 That's the kind of targeted intervention long COVID pathophysiology calls for
The study was designed to have 80% power to detect a treatment effect between the clusters, assuming that the true difference in treatment effect between clusters was 3 mmol mol 1 (which would be clinically relevant given previous reports on the association between HbA1c and vascular complications 31 )
Your provider can help you determine which protocol fits your goals and timeline
Then they took an even closer look and learned the drugs are also good at just about everything else
Moreover, when combined with immune checkpoint inhibitors (ICIs), cytokines, or immunoadjuvants (e.g., CpG), NDDSs can notably enhance the recruitment of tumor-infiltrating lymphocytes and the activation of effector T cells, resulting in a more potent anti-tumor immune response [458,459,460]
